前列腺癌免疫治疗基础研究现状及展望

Xue-ru Zhu
{"title":"前列腺癌免疫治疗基础研究现状及展望","authors":"Xue-ru Zhu","doi":"10.3760/CMA.J.ISSN.1001-9030.2019.12.002","DOIUrl":null,"url":null,"abstract":"Prostate cancer is one of the common malignant tumors in Chinese men. Most patients are diagnosed with prostate cancer at an advanced stage, and many patients fail to take the best treatment opportunity. The majority of prostate cancer patients progress to castration-resistant prostate cancer after castration, and their alternative treatment options are limited. Immunotherapy has made many breakthroughs in cancer research, and immunotherapy has been proven to bring survival benefits to patients with cancer. However, different types of immunotherapy regimens benefit differently for prostate cancer patients. This article will describe the therapeutic effects of immunotherapy in prostate cancer and its basis research. \n \n \nKey words: \nProstate cancer; Immunotherapy","PeriodicalId":10065,"journal":{"name":"中华实验外科杂志","volume":"36 1","pages":"2130-2136"},"PeriodicalIF":0.0000,"publicationDate":"2019-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Current strategies and prospects of basic research on prostate cancer immunotherapy\",\"authors\":\"Xue-ru Zhu\",\"doi\":\"10.3760/CMA.J.ISSN.1001-9030.2019.12.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Prostate cancer is one of the common malignant tumors in Chinese men. Most patients are diagnosed with prostate cancer at an advanced stage, and many patients fail to take the best treatment opportunity. The majority of prostate cancer patients progress to castration-resistant prostate cancer after castration, and their alternative treatment options are limited. Immunotherapy has made many breakthroughs in cancer research, and immunotherapy has been proven to bring survival benefits to patients with cancer. However, different types of immunotherapy regimens benefit differently for prostate cancer patients. This article will describe the therapeutic effects of immunotherapy in prostate cancer and its basis research. \\n \\n \\nKey words: \\nProstate cancer; Immunotherapy\",\"PeriodicalId\":10065,\"journal\":{\"name\":\"中华实验外科杂志\",\"volume\":\"36 1\",\"pages\":\"2130-2136\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-12-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华实验外科杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1001-9030.2019.12.002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华实验外科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1001-9030.2019.12.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

癌症是中国男性常见的恶性肿瘤之一。大多数患者被诊断为前列腺癌症晚期,许多患者未能抓住最佳治疗机会。大多数前列腺癌症患者在阉割后发展为去势耐受性前列腺癌症,他们的替代治疗选择有限。免疫疗法在癌症研究方面取得了许多突破,免疫疗法已被证明能为癌症患者带来生存益处。然而,不同类型的免疫疗法对前列腺癌症患者的益处不同。本文将介绍免疫疗法治疗前列腺癌症的疗效及其基础研究。关键词:前列腺癌症;免疫疗法
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Current strategies and prospects of basic research on prostate cancer immunotherapy
Prostate cancer is one of the common malignant tumors in Chinese men. Most patients are diagnosed with prostate cancer at an advanced stage, and many patients fail to take the best treatment opportunity. The majority of prostate cancer patients progress to castration-resistant prostate cancer after castration, and their alternative treatment options are limited. Immunotherapy has made many breakthroughs in cancer research, and immunotherapy has been proven to bring survival benefits to patients with cancer. However, different types of immunotherapy regimens benefit differently for prostate cancer patients. This article will describe the therapeutic effects of immunotherapy in prostate cancer and its basis research. Key words: Prostate cancer; Immunotherapy
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
18226
期刊介绍:
期刊最新文献
Adenosine A1R/A3R agonist AST-004 reduces brain infarction in mouse and rat models of acute ischemic stroke. Application of polybrene to increase transfection efficiency of lentiviral vector in bone marrow derived dendritic cells MicroRNA-224 mediates lipopolysaccharide-induced injury of pulmonary microvascular endothelium cells via regulating p21 Expression and clinical significance of circulating microRNA-375 and tissue Yes-associated protein 1 in colorectal cancer patients Expression and prognosis of N-α-acetyltransferase gene 10 in breast cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1